KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 456 | -98.3% | 0.00% | – |
| Q1 2022 | $37,000 | +15.6% | 26,556 | +0.3% | 0.00% | – |
| Q4 2021 | $32,000 | -54.3% | 26,473 | -0.6% | 0.00% | – |
| Q3 2021 | $70,000 | -50.0% | 26,635 | +0.8% | 0.00% | – |
| Q2 2021 | $140,000 | -20.5% | 26,430 | +1.3% | 0.00% | – |
| Q1 2021 | $176,000 | +13.5% | 26,100 | +14.0% | 0.00% | – |
| Q4 2020 | $155,000 | -43.0% | 22,900 | -36.9% | 0.00% | – |
| Q3 2020 | $272,000 | -28.8% | 36,300 | 0.0% | 0.00% | – |
| Q2 2020 | $382,000 | +198.4% | 36,300 | +148.6% | 0.00% | – |
| Q1 2020 | $128,000 | +137.0% | 14,600 | 0.0% | 0.00% | – |
| Q4 2019 | $54,000 | -3.6% | 14,600 | 0.0% | 0.00% | – |
| Q3 2019 | $56,000 | -39.8% | 14,600 | 0.0% | 0.00% | – |
| Q2 2019 | $93,000 | -23.1% | 14,600 | 0.0% | 0.00% | – |
| Q1 2019 | $121,000 | +70.4% | 14,600 | 0.0% | 0.00% | – |
| Q4 2018 | $71,000 | -50.7% | 14,600 | 0.0% | 0.00% | – |
| Q3 2018 | $144,000 | -28.0% | 14,600 | 0.0% | 0.00% | – |
| Q2 2018 | $200,000 | -13.4% | 14,600 | 0.0% | 0.00% | – |
| Q1 2018 | $231,000 | +66.2% | 14,600 | +94.7% | 0.00% | – |
| Q4 2017 | $139,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |